Advertisement
Biofrontera Inc.

Biofrontera Inc. (BFRI) Stock Overview

Explore Biofrontera Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

BFRIโ—NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.87
$0.06(6.48%)
U.S. Market is Open ยท 12:15
Advertisement

Biofrontera Inc. (BFRI)

Meyka AI Score

Z

Key Financials

Market Cap11.3M
P/E Ratio-0.91
EPS (TTM)$-0.98
ROE-4.77%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

BFRI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biofrontera Inc. (BFRI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.02, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.91 and a market capitalization of 11.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.93%
5-Day Change
-12.83%
1-Month Change
-24.96%
3-Month Change
3.98%
6-Month Change
6.19%
Year-to-Date (YTD) Change
51.40%
1-Year Change
41.15%
3-Year Change
-90.19%
5-Year Change
-99.02%
All-Time (Max) Change
-99.02%

Contact Information

781 245 1325
120 Presidential Way, Woburn, MA, 01801

Company Facts

92 Employees
IPO DateOct 29, 2021
CountryUS
Actively Trading

Frequently Asked Questions